	US 11,679,071 B2
	Urogenital cleansing composition
Dan Markusson, Växjö (SE); Anders Carlsson, Stockholm (SE); and Erik Sundquist, Saltsjöbaden (SE)
Assigned to PEPTONIC MEDICAL AB, Bromma (SE)
Appl. No. 17/998,069
Filed by PEPTONIC MEDICAL AB, Bromma (SE)
PCT Filed May 12, 2021, PCT No. PCT/EP2021/062622 § 371(c)(1), (2) Date Nov. 7, 2022, PCT Pub. No. WO2021/228937, PCT Pub. Date Nov. 18, 2021.
Claims priority of application No. 2050564-0 (SE), filed on May 13, 2020.
Prior Publication US 2023/0138911 A1, May 4, 2023
Int. Cl. A61K 8/73 (2006.01); A61K 8/92 (2006.01); A61Q 19/00 (2006.01)

CPC A61K 8/731 (2013.01) [A61K 8/922 (2013.01); A61Q 19/005 (2013.01); A61K 2800/33 (2013.01)]

20 Claims

1. A urogenital cleansing composition comprising

i) at least one non-ionic cellulose ether;

ii) an aqueous solvent;

iii) at least one triglyceride oil; and

iv) a pH-regulating agent,

said urogenital cleansing composition having a pH within the range of from 3 to 4, wherein the at least one non-ionic cellulose ether, said aqueous solvent, the at least one triglyceride oil, and said pH-regulating agent are homogenously mixed, wherein said urogenital cleansing composition does not contain any additional emulsifier, and wherein the pH-regulating agent is a lactate buffer.